These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2521 related articles for article (PubMed ID: 7087484)

  • 1. Prevention of intravascular metastases of B16 murine melanoma: adjuvant chemotherapy with actinomycin D.
    Richie JP
    J Surg Oncol; 1982 Jul; 20(3):145-50. PubMed ID: 7087484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of mouse melanoma cell lines by their mortal malignancy using an experimental metastatic model.
    Nakamura K; Yoshikawa N; Yamaguchi Y; Kagota S; Shinozuka K; Kunitomo M
    Life Sci; 2002 Jan; 70(7):791-8. PubMed ID: 11833741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the immunomodulator LS 2616 on growth and metastasis of the murine B16-F10 melanoma.
    Kalland T
    Cancer Res; 1986 Jun; 46(6):3018-22. PubMed ID: 3486041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc- and 111In-labeled alpha-melanocyte-stimulating hormone peptides as imaging probes for primary and pulmonary metastatic melanoma detection.
    Miao Y; Benwell K; Quinn TP
    J Nucl Med; 2007 Jan; 48(1):73-80. PubMed ID: 17204701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor.
    Chirivi RG; Garofalo A; Crimmin MJ; Bawden LJ; Stoppacciaro A; Brown PD; Giavazzi R
    Int J Cancer; 1994 Aug; 58(3):460-4. PubMed ID: 8050828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.
    Wang BS; McLoughlin GA; Richie JP; Mannick JA
    Cancer Res; 1980 Feb; 40(2):288-92. PubMed ID: 7356511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties.
    Irimura T; Gonzalez R; Nicolson GL
    Cancer Res; 1981 Sep; 41(9 Pt 1):3411-8. PubMed ID: 7260906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases.
    Poste G; Doll J; Brown AE; Tzeng J; Zeidman I
    Cancer Res; 1982 Jul; 42(7):2770-8. PubMed ID: 7083167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic inefficiency in mice bearing B16 melanomas.
    Weiss L; Mayhew E; Rapp DG; Holmes JC
    Br J Cancer; 1982 Jan; 45(1):44-53. PubMed ID: 7059464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity.
    Fidler IJ; Gersten DM; Budmen MB
    Cancer Res; 1976 Sep; 36(9 pt.1):3160-5. PubMed ID: 975082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of development of murine melanoma lung metastases by systemic administration of recombinant platelet factor 4.
    Kolber DL; Knisely TL; Maione TE
    J Natl Cancer Inst; 1995 Feb; 87(4):304-9. PubMed ID: 7707422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine.
    Albini A; D'Agostini F; Giunciuglio D; Paglieri I; Balansky R; De Flora S
    Int J Cancer; 1995 Mar; 61(1):121-9. PubMed ID: 7705924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin.
    Gautam A; Waldrep JC; Densmore CL; Koshkina N; Melton S; Roberts L; Gilbert B; Knight V
    Gene Ther; 2002 Mar; 9(5):353-7. PubMed ID: 11938455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs.
    Timmons JJ; Cohessy S; Wong ET
    J Vis Exp; 2016 May; (111):. PubMed ID: 27285567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines.
    Fidler IJ; Nicolson GL
    J Natl Cancer Inst; 1976 Nov; 57(5):1199-202. PubMed ID: 1003551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.
    Rosenberg SA; Mulé JJ; Spiess PJ; Reichert CM; Schwarz SL
    J Exp Med; 1985 May; 161(5):1169-88. PubMed ID: 3886826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergism between N-acetylcysteine and doxorubicin in the prevention of tumorigenicity and metastasis in murine models.
    De Flora S; D'Agostini F; Masiello L; Giunciuglio D; Albini A
    Int J Cancer; 1996 Sep; 67(6):842-8. PubMed ID: 8824557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of B16 melanoma lung colonization by syngeneic monoclonal antibodies.
    Herd ZL
    Cancer Res; 1987 May; 47(10):2696-703. PubMed ID: 3552203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell.
    Fidler IJ; Talmadge JE
    Cancer Res; 1986 Oct; 46(10):5167-71. PubMed ID: 3756870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of thymosin beta4 in tumor metastasis and angiogenesis.
    Cha HJ; Jeong MJ; Kleinman HK
    J Natl Cancer Inst; 2003 Nov; 95(22):1674-80. PubMed ID: 14625258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 127.